ARTL

Artelo Biosciences Inc.

Price

$3.94

return (12m)

-97.40%

p/e

0.26

p/bv

0.25

DIVIDEND YIELD

0.00%

ARTL price

Artelo Biosciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ARTL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-35.62%

3 months

-64.41%

1 year

-97.40%

2 years

-97.71%

5 years

-99.81%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals ARTL

Valuation

P/E

0.26

Sector 1.09

Industry -1.78

P/BV

0.25

Sector 1.86

Industry 1.35

P/Revenue (PSR)

Sector 1.55

Industry 2.25

EV/EBITDA

1.23

Sector -47.62

Industry -42.38

EV/EBIT

1.23

Sector -27.52

Industry -45.58

P/EBITDA

-0.10

Sector -32.64

Industry -23.10

P/EBIT

-0.10

Sector -43.02

Industry -27.18

P/Total Assets

0.19

Sector 0.87

Industry 0.82

P/Net Current Assets

0.42

Sector -27.09

Industry -72.46

P/Working Capital

0.42

Sector -4.05

Industry -2.10

EPS

15.78

Sector -0.70

Industry -1.11

BVPS

16.58

Sector 4.34

Industry 2.54

Efficiency

Gross Margin

0.00%

Sector 49.36%

Industry 50.48%

EBITDA Margin

Sector -283.40%

Industry -17,123,193.33%

EBIT Margin

Sector -164.84%

Industry -17,075,660.18%

Operating Margin

0.00%

Sector -19.73%

Industry -25.75%

Net Profit Margins

0.00%

Sector -24.22%

Industry -27.82%

Asset Turnover

0.00

Sector 0.13

Industry 0.06

Profitability

ROE

95.16%

Sector -24.32%

Industry -33.33%

ROA

73.62%

Sector -24.41%

Industry -45.72%

ROIC

-363.70%

Sector -529.97%

Industry -855.00%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

3.00

Sector 1.90

Industry 2.51

Net Debt / EBITDA

1.73

Sector -4.96

Industry -8.98

Net Debt / EBIT

1.73

Sector -3.08

Industry -37.38

Net Debt / Equity

-0.84

Sector -0.45

Industry -1.16

Gross Debt / Equity

0.00

Sector -0.74

Industry -0.56

Equity/Assets

0.77

Sector 0.46

Industry 0.52

Liabilities/Assets

0.23

Sector 0.49

Industry 0.47

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-5.54%

Sector -

Industry -

Fundamentals ARTL

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Artelo Biosciences ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$3.94

Fair Value

$76.73

Upside

1,847.34%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ARTL Artelo Biosciences Inc.	$3.94	-97.40%	0.00%	0.26	0.25	95.16%	0.00%
LLY Eli Lilly and Compay	$1,152.93	54.29%	0.59%	38.16	30.09	78.84%	33.53%
SNY Sanofi	$42.48	-7.32%	4.17%	3.97	0.73	18.43%	14.25%
GSK GlaxoSmithKline PLC	$50.22	29.16%	3.54%	15.39	4.35	28.24%	14.54%
CRMD CorMedix Inc.	$7.72	-31.07%	0.00%	3.22	1.31	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$23.62	-14.54%	0.00%	13.18	1.35	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$12.19	-17.43%	0.69%	27.59	2.49	9.03%	10.14%
ENLV Enlivex Therapeutics Ltd.	$0.81	-94.85%	0.00%	0.01	0.01	63.85%	0.00%
ISRG Intuitive Surgical Inc.	$393.33	-10.35%	0.00%	44.01	7.60	17.26%	28.62%
NVS Novartis AG	$140.37	16.41%	2.22%	20.89	6.35	30.39%	23.28%
TMO Thermo Fisher Scientific Inc.	$651.45	36.43%	0.28%	34.71	4.60	13.25%	15.07%
ABT Abbott Laboratories	$102.61	-22.85%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.13	0.84%	3.11%	22.28	2.31	10.35%	14.02%
BSX Boston Scientific Corp.	$43.34	-55.70%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$86.42	-29.33%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$224.99	-16.77%	0.80%	21.51	4.98	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$511.65	-22.02%	0.00%	35.48	25.07	70.67%	25.03%
HCA HCA Healthcare Inc.	$427.71	7.02%	0.70%	12.06	-29.52	-244.72%	10.07%
COHR Coherent Inc.	$317.36	190.86%	0.00%	75.62	5.36	7.09%	11.19%
DHR Danaher Corporation	$211.81	10.60%	0.68%	37.21	2.83	7.61%	15.95%
SYK Stryker Corp.	$275.12	-26.01%	1.26%	28.38	4.41	15.55%	14.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ARTL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Artelo Biosciences

Artelo Biosciences Inc.

Average Investor10 user rating

4.0 (1 people)

United States

15 years

Founded: 2011

2015

Time since IPO - 11 years

5

Employees

Artelo Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.23 million, with shareholders equity totaling $5.00 million.

The company employs approximately 5 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Artelo Biosciences Inc. reported $- in revenue, generating net income of $4.76 million.

Key financial metrics include a P/E ratio of 0.26, a price-to-book (P/B) ratio of 0.25, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ARTL.

Market cap

$1.23 million

Net worth

$5.00 million

$4,997,000.00

Assets

$6.46 million

$6,459,000.00

Total Shares Outstanding

301.33 Thousand

301,000

Average Daily Trading Volume

$65.68 Thousand

$65,682.90

Sector

Health

Industry

Pharmaceutical Products

ARTL

ARTL revenue and profits

Financial Results ARTL

DRAG THE FRAME TO SEE MORE DATA

ARTL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$88.84 22,33% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$275.28 --3,05% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$65.11 104,94% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$386.22 55,41% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$42.48 --7,32% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,152.93 54,29% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$427.71 7,02% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$140.37 16,41% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35